135 related articles for article (PubMed ID: 2322789)
21. Possible causes of a positive Haemoccult-II test in a population screening study for colorectal neoplasia.
Sommer T; Kronborg O
Eur J Cancer Prev; 1996 Jun; 5(3):181-7. PubMed ID: 8818607
[TBL] [Abstract][Full Text] [Related]
22. Controlled trial of faecal occult blood testing in the detection of colorectal cancer.
Hardcastle JD; Farrands PA; Balfour TW; Chamberlain J; Amar SS; Sheldon MG
Lancet; 1983 Jul; 2(8340):1-4. PubMed ID: 6134884
[TBL] [Abstract][Full Text] [Related]
23. Chemical and immunological testing for faecal occult blood in screening subjects at risk of familial colorectal cancer.
Hunt LM; Rooney PS; Bostock K; Robinson MH; Hardcastle JD; Armitage NC
Gut; 1997 Jan; 40(1):110-2. PubMed ID: 9155586
[TBL] [Abstract][Full Text] [Related]
24. Is dietary restriction always necessary in Haemoccult screening for colorectal neoplasia?
Robinson MH; Thomas WM; Pye G; Hardcastle JD; Mangham CM
Eur J Surg Oncol; 1993 Dec; 19(6):539-42. PubMed ID: 8270040
[TBL] [Abstract][Full Text] [Related]
25. Faecal occult blood testing in symptomatic patients: comparison of three tests.
Tate JJ; Northway J; Royle GT; Taylor I
Br J Surg; 1990 May; 77(5):523-6. PubMed ID: 2354334
[TBL] [Abstract][Full Text] [Related]
26. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
[TBL] [Abstract][Full Text] [Related]
27. The effect of self-administered faecal occult blood tests on compliance with screening for colorectal cancer: results of a survey of those invited.
Hunter W; Farmer A; Mant D; Verne J; Northover J; Fitzpatrick R
Fam Pract; 1991 Dec; 8(4):367-72. PubMed ID: 1800202
[TBL] [Abstract][Full Text] [Related]
28. Acceptability of opportunistic screening for occult gastrointestinal blood loss.
Hobbs FD; Cherry RC; Fielding JW; Pike L; Holder R
BMJ; 1992 Feb; 304(6825):483-6. PubMed ID: 1547423
[TBL] [Abstract][Full Text] [Related]
29. Immunoassay-based screening for colorectal cancer. More colonoscopies performed and more cancers detected than with Haemoccult.
Prescrire Int; 2012 Dec; 21(133):299-302. PubMed ID: 23373100
[TBL] [Abstract][Full Text] [Related]
30. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
[TBL] [Abstract][Full Text] [Related]
31. Colorectal cancer prevention. An approach to increasing compliance in a faecal occult blood test screening programme.
Hart AR; Eaden J; Barnett S; de Bono AM; Mayberry JF
J Epidemiol Community Health; 1998 Dec; 52(12):818-20. PubMed ID: 10396524
[TBL] [Abstract][Full Text] [Related]
32. Early detection of colorectal cancer with faecal occult blood test screening.
Paimela H; Malila N; Palva T; Hakulinen T; Vertio H; Järvinen H
Br J Surg; 2010 Oct; 97(10):1567-71. PubMed ID: 20603855
[TBL] [Abstract][Full Text] [Related]
33. Screening for colorectal neoplasms with a new immunological human faecal haemoglobin and albumin test.
Sieg A; Hertel A; John MR; Lüthgens K; Schmidt-Gayk H
Eur J Cancer Prev; 1998 Aug; 7(4):279-85. PubMed ID: 9806116
[TBL] [Abstract][Full Text] [Related]
34. Experience with haemoccult screening in Hungary. A multicenter trial.
Siba S
Hepatogastroenterology; 1983 Feb; 30(1):27-9. PubMed ID: 6601046
[TBL] [Abstract][Full Text] [Related]
35. The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer.
Robinson MH; Hardcastle JD; Moss SM; Amar SS; Chamberlain JO; Armitage NC; Scholefield JH; Mangham CM
Gut; 1999 Oct; 45(4):588-92. PubMed ID: 10486370
[TBL] [Abstract][Full Text] [Related]
36. Haemoccult testing as an indicator of recurrent colorectal cancer: a 5-year prospective study.
Crowson MC; Jewkes AJ; Acheson N; Fielding J
Eur J Surg Oncol; 1991 Jun; 17(3):281-4. PubMed ID: 2044781
[TBL] [Abstract][Full Text] [Related]
37. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy.
Winawer SJ; Flehinger BJ; Schottenfeld D; Miller DG
J Natl Cancer Inst; 1993 Aug; 85(16):1311-8. PubMed ID: 8340943
[TBL] [Abstract][Full Text] [Related]
38. Randomised study of screening for colorectal cancer with faecal-occult-blood test.
Kronborg O; Fenger C; Olsen J; Jørgensen OD; Søndergaard O
Lancet; 1996 Nov; 348(9040):1467-71. PubMed ID: 8942774
[TBL] [Abstract][Full Text] [Related]
39. Screening for colorectal neoplasia with faecal occult blood testing compared with flexible sigmoidoscopy directly in a 55-56 years' old population.
Brevinge H; Lindholm E; Buntzen S; Kewenter J
Int J Colorectal Dis; 1997; 12(5):291-5. PubMed ID: 9401844
[TBL] [Abstract][Full Text] [Related]
40. Self-administered faecal occult blood tests do not increase compliance with screening for colorectal cancer: results of a randomized controlled trial.
Verne J; Kettner J; Mant D; Farmer A; Mortenson N; Northover J
Eur J Cancer Prev; 1993 Jul; 2(4):301-5. PubMed ID: 8358281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
